Tafamidis ameliorates TTR amyloidosis by acting as an orthosteric stabiliser of TTR dimers through binding to the thyroxine-binding site located at the TTR dimer–dimer interface [42, 43] (Figure 3a). The gene discussed is TTR; the disease is amyloidosis.